Education
About Us
Working with TipRanks
Follow Us
Telo Genomics Corp (TSE:TELO)
:TELO
TELO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.07 - C$0.20
Previous CloseN/A
Volume60.50K
Average Volume (3M)44.48K
Market Cap
C$7.50M
Enterprise ValueC$10.25M
Total Cash (Recent Filing)C$1.25M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.16
Next Earnings
Nov 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding100,018,936
10 Day Avg. Volume35,500
30 Day Avg. Volume44,483
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Telo Genomics Corp News
TELO FAQ
What was Telo Genomics Corp’s price range in the past 12 months?
Telo Genomics Corp lowest stock price was C$0.07 and its highest was C$0.20 in the past 12 months.
What is Telo Genomics Corp’s market cap?
Telo Genomics Corp’s market cap is C$7.50M.
When is Telo Genomics Corp’s upcoming earnings report date?
Telo Genomics Corp’s upcoming earnings report date is Nov 04, 2025 which is in 54 days.
How were Telo Genomics Corp’s earnings last quarter?
Telo Genomics Corp released its earnings results on May 27, 2025. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
Is Telo Genomics Corp overvalued?
According to Wall Street analysts Telo Genomics Corp’s price is currently Overvalued.
Does Telo Genomics Corp pay dividends?
Telo Genomics Corp does not currently pay dividends.
What is Telo Genomics Corp’s EPS estimate?
Telo Genomics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Telo Genomics Corp have?
Telo Genomics Corp has 100,018,936 shares outstanding.
What happened to Telo Genomics Corp’s price movement after its last earnings report?
Telo Genomics Corp reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Telo Genomics Corp?
Currently, no hedge funds are holding shares in TSE:TELO
Company Description
Telo Genomics Corp
Telo Genomics Corp (TELO) is a biotechnology company focused on developing and commercializing innovative diagnostic and prognostic products to improve patient outcomes. The company operates in the healthcare sector, specifically within the field of genomic testing. Its core products leverage advanced genomic analysis techniques to provide insights into the progression of diseases, particularly in oncology and other critical health conditions.
Technical Analysis
BioMark Diagnostics
―
―
StageZero Life Sciences Ltd
―
Avricore Health
―
Izotropic
―
Options Prices
Currently, No data available
---